# Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning

> **NCT00466674** · PHASE2 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 13 (actual)

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** reduced intensity conditioning

## Key facts

- **NCT ID:** NCT00466674
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466674, "Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00466674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*